Moreover, Shi et al. demonstrated that CAR-T cells targeting CD99 specifically recognized and eradicated T-ALL cell lines and primary tumor cells without normal blood cells toxicity [181]. The gene discussed is CD99; the disease is acute lymphoblastic leukemia.